InnovAge Holding（INNV）株式概要
イノヴェイジ・ホールディング・コーポレーションは、介護とサポートを必要とする高齢者が自宅やコミュニティで自立した生活を送れるよう、様々な医療・付帯サービスを管理・提供している。 詳細
INNV Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
InnovAge Holding Corp. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$10.61 |
| 52週高値 | US$12.64 |
| 52週安値 | US$3.26 |
| ベータ | 0.40 |
| 1ヶ月の変化 | -8.38% |
| 3ヶ月変化 | 49.02% |
| 1年変化 | 209.33% |
| 3年間の変化 | 91.86% |
| 5年間の変化 | -28.70% |
| IPOからの変化 | -56.16% |
最新ニュース
ナラティブ更新 • Jun 19
INNV: Unchanged Assumptions And 2026 Guidance Will Restrain Stock Upside
Analysts have kept their fair value estimate for InnovAge Holding steady at $7.00 per share, reflecting largely unchanged assumptions for the discount rate, revenue growth, profit margin, and future P/E in their updated price target work. What’s in the News for InnovAge Holding InnovAge Holding issued updated corporate guidance for fiscal 2026, providing investors with a more detailed view of expected performance.ナラティブ更新 • Jun 05
INNV: 2026 Guidance And Margin Outlook Will Shape Balanced Risk Reward
Analysts have kept their price target on InnovAge Holding steady at $7.00, pointing to slightly lower modeled revenue growth, a higher projected profit margin, and a modestly reduced future P/E assumption as key drivers of the updated view. What's in the News InnovAge Holding raised earnings guidance for fiscal 2026, with total revenues now expected in a range of US$950 million to US$975 million.ナラティブ更新 • May 16
INNV: Updated Modeling And 2026 Guidance Will Shape Balanced Risk Reward Outlook
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling related to fair value, discount rate, growth expectations, profit margins, and future P/E assumptions. Analyst Commentary JPMorgan raised its price target on InnovAge Holding to US$7 from US$5 after updating its model, while maintaining an Underweight rating on the stock.Recent updates
ナラティブ更新 • Jun 19
INNV: Unchanged Assumptions And 2026 Guidance Will Restrain Stock Upside
Analysts have kept their fair value estimate for InnovAge Holding steady at $7.00 per share, reflecting largely unchanged assumptions for the discount rate, revenue growth, profit margin, and future P/E in their updated price target work. What’s in the News for InnovAge Holding InnovAge Holding issued updated corporate guidance for fiscal 2026, providing investors with a more detailed view of expected performance.ナラティブ更新 • Jun 05
INNV: 2026 Guidance And Margin Outlook Will Shape Balanced Risk Reward
Analysts have kept their price target on InnovAge Holding steady at $7.00, pointing to slightly lower modeled revenue growth, a higher projected profit margin, and a modestly reduced future P/E assumption as key drivers of the updated view. What's in the News InnovAge Holding raised earnings guidance for fiscal 2026, with total revenues now expected in a range of US$950 million to US$975 million.ナラティブ更新 • May 16
INNV: Updated Modeling And 2026 Guidance Will Shape Balanced Risk Reward Outlook
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling related to fair value, discount rate, growth expectations, profit margins, and future P/E assumptions. Analyst Commentary JPMorgan raised its price target on InnovAge Holding to US$7 from US$5 after updating its model, while maintaining an Underweight rating on the stock.ナラティブ更新 • Apr 20
INNV: Updated Modeling And 2026 Guidance Will Likely Limit Future Share Upside
Analysts raised their price target on InnovAge Holding to $7 from $5, citing updated company modeling as the key driver of the change. Analyst Commentary The move to a US$7 price target signals that at least one major firm sees enough change in the underlying assumptions to justify a higher valuation for InnovAge Holding, even while keeping a cautious stance on the stock.ナラティブ更新 • Apr 05
INNV: Updated Modeling And 2026 Guidance Will Likely Temper Upside Expectations
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling assumptions that incorporate refined views on fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary JPMorgan's updated price target signals a fresh look at InnovAge Holding's valuation framework, even as the firm maintains an Underweight stance.ナラティブ更新 • Mar 22
INNV: Raised Outlook And Model Assumptions Will Likely Prove Overly Optimistic
Analysts have lifted their price target on InnovAge Holding to $7 from $5, reflecting updated models that refine assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Bullish Takeaways Bullish analysts view the lift in the price target to $7 as a sign that updated assumptions on fair value and discount rates support a higher implied equity valuation.ナラティブ更新 • Mar 08
INNV: Raised Outlook And P/E Assumptions Will Likely Prove Overly Optimistic
Analysts have lifted their price target on InnovAge Holding to $7 from $5, reflecting updated modeling assumptions around fair value, discount rate, revenue growth, profit margin and future P/E that collectively support a modestly higher valuation framework. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a US$7 price target as recognition that updated fair value work supports a somewhat higher valuation range than before.Seeking Alpha • Feb 23
InnovAge: The Headwinds Are Priced In, The Growth May Not Be
Summary InnovAge Holding Corp. delivers strong operational execution, driving significant revenue and margin expansion through its PACE model for elderly care. INNV’s revenue rose 14.7% year-over-year, fueled by participant growth and capitation rate adjustments across established centers. Disciplined cost management and SG&A reductions have expanded center-level contribution margin to 22% and adjusted EBITDA margin to 9.2%. Despite Medicaid eligibility headwinds, INNV’s improved processes and in-house pharmacy transition support a bullish outlook on sustainability and leverage. Read the full article on Seeking Alphaナラティブ更新 • Feb 21
INNV: Future Margin Assumptions Will Likely Prove Overly Optimistic
Analysts have revised their price target on InnovAge Holding, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these factors result in a new target of $7.00, up from $5.00.分析記事 • Feb 06
Earnings Beat: InnovAge Holding Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
InnovAge Holding Corp. ( NASDAQ:INNV ) investors will be delighted, with the company turning in some strong numbers...分析記事 • Jan 17
InnovAge Holding Corp.'s (NASDAQ:INNV) Price In Tune With Revenues
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.9x right...分析記事 • Dec 13
InnovAge Holding (NASDAQ:INNV) Might Be Having Difficulty Using Its Capital Effectively
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...分析記事 • Nov 07
InnovAge Holding Corp. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
As you might know, InnovAge Holding Corp. ( NASDAQ:INNV ) just kicked off its latest quarterly results with some very...分析記事 • Nov 03
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Sep 10
Improved Revenues Required Before InnovAge Holding Corp. (NASDAQ:INNV) Stock's 32% Jump Looks Justified
InnovAge Holding Corp. ( NASDAQ:INNV ) shareholders would be excited to see that the share price has had a great month...分析記事 • Jul 08
Health Check: How Prudently Does InnovAge Holding (NASDAQ:INNV) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...新しいナラティブ • May 29
Expanding US Senior Care Integration Will Drive Healthcare Transformation
Enrollment growth and efficient geographic expansion are positioning the company for sustained revenue gains and scalable growth.分析記事 • May 09
After Leaping 36% InnovAge Holding Corp. (NASDAQ:INNV) Shares Are Not Flying Under The Radar
InnovAge Holding Corp. ( NASDAQ:INNV ) shares have had a really impressive month, gaining 36% after a shaky period...分析記事 • Apr 09
Is InnovAge Holding (NASDAQ:INNV) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...分析記事 • Feb 06
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.6x may look like a pretty appealing...分析記事 • Nov 07
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 1.1x seems...分析記事 • Aug 20
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Jun 28
InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story
InnovAge Holding Corp. ( NASDAQ:INNV ) shares have had a really impressive month, gaining 30% after a shaky period...分析記事 • May 07
Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.8x right...分析記事 • Mar 15
InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...分析記事 • Jan 06
Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)
There wouldn't be many who think InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 1.1x is...株主還元
| INNV | US Healthcare | US 市場 | |
|---|---|---|---|
| 7D | -5.1% | 0.2% | 1.7% |
| 1Y | 209.3% | 32.8% | 20.0% |
業界別リターン: INNV過去 1 年間で32.8 % の収益を上げたUS Healthcare業界を上回りました。
リターン対市場: INNV過去 1 年間で20 % の収益を上げたUS市場を上回りました。
価格変動
| INNV volatility | |
|---|---|
| INNV Average Weekly Movement | 7.3% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
安定した株価: INNV 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: INNVの 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1989 | 2,440 | Patrick Blair | www.innovage.com |
InnovAge Holding Corp.は、介護とサポートを必要とする高齢者が自宅やコミュニティで自立して生活できるよう、様々な医療サービスや付帯サービスを管理・提供している。同社は、高齢者包括ケアプログラム（PACE）方式で事業を運営している。同社はまた、熟練介護、非熟練介護、個人介護からなる在宅介護サービス、プライマリーケア、理学療法、作業療法、言語療法、歯科サービス、精神保健・精神科サービス、食事、アクティビティなどのセンター内サービス、PACEセンターへの送迎、第三者の医療予約、ケアマネジメントを提供している。米国内の参加者を対象に、コロラド州、カリフォルニア州、ニューメキシコ州、ペンシルベニア州、フロリダ州、バージニア州でPACEセンターを運営している。同社は以前はTCO Group Holdings, Inc.として知られていたが、2021年1月にInnovAge Holding Corp.に社名を変更した。1989年に設立され、コロラド州デンバーに本社を置く。
InnovAge Holding Corp. 基礎のまとめ
| INNV 基礎統計学 | |
|---|---|
| 時価総額 | US$1.45b |
| 収益（TTM） | -US$11.61m |
| 売上高(TTM) | US$949.17m |
1.5x
P/Sレシオ-124.1x
PER（株価収益率INNV は割高か？
公正価値と評価分析を参照収益と収入
| INNV 損益計算書（TTM） | |
|---|---|
| 収益 | US$949.17m |
| 売上原価 | US$300.41m |
| 売上総利益 | US$648.76m |
| その他の費用 | US$660.37m |
| 収益 | -US$11.61m |
直近の収益報告
Mar 31, 2026
次回決算日
該当なし
| 一株当たり利益（EPS） | -0.086 |
| グロス・マージン | 68.35% |
| 純利益率 | -1.22% |
| 有利子負債／自己資本比率 | 22.4% |
INNV の長期的なパフォーマンスは？
過去の実績と比較を見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/08/14 23:52 |
| 終値 | 2026/08/14 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/06/30 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
InnovAge Holding Corp. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。14
| アナリスト | 機関 |
|---|---|
| Vikram Kesavabhotla | Baird |
| Steven Valiquette | Barclays |
| Sarah James | Barclays |